Bacteriemia Producida Por P Aeruginosa clinical trials

Explore recruiting bacteriemia producida por p aeruginosa clinical trials.

Also recruiting in Europe

Bacteriemia Producida Por P Aeruginosa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized (SHORTEN-2) clinical trial with a DOOR/RADAR analysis.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Bacteriemia Producida Por P Aeruginosa trials by city

Bacteriemia Producida Por P Aeruginosa in Toronto Bacteriemia Producida Por P Aeruginosa in Vancouver Bacteriemia Producida Por P Aeruginosa in Montreal Bacteriemia Producida Por P Aeruginosa in Calgary Bacteriemia Producida Por P Aeruginosa in Edmonton Bacteriemia Producida Por P Aeruginosa in Ottawa Bacteriemia Producida Por P Aeruginosa in Winnipeg Bacteriemia Producida Por P Aeruginosa in Quebec City Bacteriemia Producida Por P Aeruginosa in Hamilton Bacteriemia Producida Por P Aeruginosa in Kitchener Bacteriemia Producida Por P Aeruginosa in London Bacteriemia Producida Por P Aeruginosa in Halifax Bacteriemia Producida Por P Aeruginosa in New York Bacteriemia Producida Por P Aeruginosa in Los Angeles Bacteriemia Producida Por P Aeruginosa in Chicago Bacteriemia Producida Por P Aeruginosa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease